About Us

The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.

To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.

MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada and the World Intellectual Property Organization (WIPO). MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.

Featured

MedsPaL

02 March 2020

LAPaL

MPP in Numbers

0

patent holders with MPP signed agreements

0

generic manufacturers and product developers have sublicences from MPP

0 Bn
doses of treatment supplied (Jan 2012 - Dec 2023)
US$0 Bn
dollars saved through MPP'S licences (Jan 2012 - Dec 2023)
By the end of 2030
US$0 Bn
projected dollars saved
0
countries have benefited from access to MPP-licensed products
0 Mn
patient-years of treatment through MPPs generic partners (Jan 2012 - Dec 2023)
0
deaths averted (Jan 2012 - Dec 2023)
By the end of 2030
0
deaths averted

For Everyone Everywhere

Discover where we helped and what we have achieved

 

Patent and licensing status: last updated on 1st October 2023. Disclaimer | Product availability data from MPP sublicensees: last updated in September 2024 (data as of 30th June 2024) | Note: Sales may occur in countries in the absence of registration via procurement channels, registration waivers and/or exemptions

Interactive Map: Click here to view full size

Impact Stories

Key Publications

Contact Us

MPP Logo

Subscribe to our Newsletter

Founded & funded by

Unitaid Logo

Other funders